Flatiron Health, a leading health technology company renowned for its application of real-world data (RWD) to improve cancer care and enhance research initiatives, has proudly announced the continuation of its strategic partnership with the National Comprehensive Cancer Network® (NCCN®), a distinguished not-for-profit alliance of premier cancer centers focused on elevating patient care, pioneering research, and advancing educational efforts. This enduring collaboration was first established in 2014 with the inception of the NCCN Quality & Outcomes Database—a pioneering cloud-based repository that integrates data from NCCN Member Institutions to foster improvements in oncology practices.
“We are dedicated to making sure that every individual, regardless of their location, has access to cancer care of the highest quality that is informed by the latest evidence and expert consensus,” expressed Crystal S. Denlinger, MD, Chief Executive Officer at NCCN. “Continuing our partnership with Flatiron enables us to effectively utilize real-world data to pursue this goal vigorously. We are thrilled to renew our commitment to collaboratively enhancing the lives of people affected by cancer.”
Flatiron Health and NCCN Renew Partnership to Advance Cancer Care with Real-World Data
The renewal of this partnership not only reinvigorates the commitment of both organizations to leverage cutting-edge data for cancer care enhancement but also extends a relationship that has been pivotal in developing research methodologies that inform better patient outcomes. Over the years, this alliance has facilitated numerous quality improvement initiatives, which have significantly contributed to refining the precision and effectiveness of cancer treatments administered across NCCN Member Institutions.
Additionally, the collaboration aims to expand the use of Flatiron’s meticulously curated datasets to further support the cancer centers associated with NCCN in their ongoing efforts to assess and elevate the quality of care they provide. This will include the ongoing development of sophisticated metrics and benchmarks designed to rigorously measure and enhance patient care quality.
Neal Meropol, MD, Vice President of Research Oncology at Flatiron Health, remarked, “The renewal of our long-standing relationship with NCCN represents a thrilling opportunity and a progressive step towards fulfilling our mission to improve and extend lives by learning from the experiences of every cancer patient. This partnership is set to broaden the impact of real-world data on bridging evidence gaps and elevating care standards alongside the top cancer centers that comprise the NCCN alliance.”
Resource: Flatiron Health, April 10, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
